Alternatives for Treatment of Presbyopia

Main Article Content

Arthit Kaewnopharat

Abstract

Presbyopia, defined as a physiological loss of accommodation, is found in all individuals over the age of 40. It is one of the most common refractive errors, predicted to affect approximately 1.4 billion people worldwide in 2020. Loss of near vision with dependency on spectacles may be distressing and the demands for alternative treatments of presbyopia such as monovision, conductive keratoplasty, multifocal LASIK, corneal inlay, femtosecond laser treatment, and intraocular lens treatment become an important concern. The problem is that understanding of accommodation as a cause remains unclear, making the possibility of curing this condition one of the most challenging frontiers of ophthalmology.

Article Details

How to Cite
Kaewnopharat, A. (2018). Alternatives for Treatment of Presbyopia. Vajira Medical Journal : Journal of Urban Medicine, 62(2), 119–126. Retrieved from https://he02.tci-thaijo.org/index.php/VMED/article/view/195718
Section
Review Articles

References

1. Holden BA, Fricke TR, Ho SM, Wong R, Schlenther G, Cronjé S, et al. Global vision Impairment due to uncorrected presbyopia. Arch Ophthalmol. 2008;126(12):1731–39.

2. Hamill MB, Berdy GJ, Davidson RS, Majmudar PA, Randleman JB, Shamie N. Refractive surgery: basic and clinical science course section 13. 2016-2017 ed. San Francisco: American Academy of Ophthalmology; 2016.

3. Jick SL, Beardsley TL, Brasington CR, Buznego C, Grostern RJ, Park L, et al. Lens and cataract: basic and clinical science course section 11. 2016-2017 ed. San Francisco: American Academy of Ophthalmology; 2016.

4. Grzybowski A, Schachar RA, Gaca-Wysocka M, Schachar IH, Kamangar F, Pierscionek BK. Mechanism of accommodation assessed by change in precisely registered ocular images associated with concurrent change in auto-refraction. Graefes Arch Clin Exp Ophthalmol. 2018;256(2):395-402.

5. Zheleznyak L, Sabesan R, Oh JS, MacRae S, Yoon G. Modified monovision with spherical aberration to improve presbyopic through-focus visual performance. Invest Ophthalmol Vis Sci. 2013;54:3157-65.

6. Hamilton DR, Davidorf JM, Maloney RK. Anterior ciliary sclerotomy for treatment of presbyopia: a prospective controlled study. Ophthalmology. 2002;109(11):1970-6.

7. Ye PP, Xu W, Xu HS, Li ZC, Shi JT, He FY, et al. Conductive keratoplasty: an approach for the correction of residual hyperopia in post-lasik pseudophakia. Int J Ophthalmol. 2012;5(5):630-3.

8. Schultz J. Presby-LASIK holds promise for young presbyopes. Ocular Surgery News Europe/ Asia-Pacific Edition (Archive) [Internet]. 2005 [cited 2018 Feb 18]. Available from:https://www.healio.com/ophthalmology/news/print/ocular-surgery-news-europeasia-edition/%7Ba62e6062-1914-49ac-8d9b-e9f08ba7ba9e%7D/presby-lasikholds-promise-for-young-presbyopes

9. Alio JL, Chaubard JJ, Caliz a, Sala E, Patel S. Correction of presbyopia by technovision central multifocal LASIK (presbyLASIK). J Refract Surg. 2006;22(5):453-60.

10. Jackson WB, Tuan KM, Mintsioulis G. Aspheric wavefront-guided LASIK to treat hyperopic presbyopia: 12-month results with the VISX platform. J Refract Surg. 2011;27(7):519-29.

11. Schlote T, Heuberger A. Multifocal corneal ablation (Supracor) in hyperopic presbyopia: 1-year results in a cross-sectional study. Euro J Ophthalmol. 2017;27(4):438-42.

12. Pinelli R, Ortiz D, Simonetto A, Bacchi C, Sala E, Alio JL. Correction of presbyopia in hyperopia with a center-distance, paracentral-near technique using the Technolas 217z platform. J Refract Surg. 2008;24(5):494-500.

13. Epstein RL, Gurgos MA. Presbyopia treatment by monocular peripheral presbyLASIK. J Refrct Surg. 2009;25(6):516-23.

14. Soler Tomas JR, Fuentes-Paez G, Burillo S. Symmetrical versus asymmetrical presbyLASIK: results after 18 months and patient satisfaction. Cornea. 2015;34(6):651-7.

15. Moarefi MA, Bafna S, Wiley W. A review of presbyopia treatment with corneal inlays. Ophthalmol Ther. 2017;6(1):55-65.

16. Srinivasan S. Corneal inlays for spectacle independence: friend or foe? J Cataract Refract Surg. 2016;42(7):953-4.

17. Moshirfar M, Desautels JD, Wallace RT, Koen N, Hoopes PC. Comparison of FDA safety and efficacy data for KAMRA and Raindrop corneal inlays. Int J Ophthalmol. 2017;10(9):1446-51.

18. Arlt EM, Krall EM, Moussa S, Grabner G, Dexl AK. Implantable inlay devices for presbyopia: the evidence to date. Clin Ophthalmol. 2015;9:129-37.

19. Alio JL, Vega-Estrada A. Accommodative intraocular lenses: where are we and where we are going. Eye and Vision [Internet]. 2017 [cited 2018 Feb 23];4:16. Available from:https://eandv.biomedcentral.com/articles/10.1186/s40662-017-0077-7

20. Holzer MP, Knorz MC, Tomalla M, Neuhann TM, Auffarth GU. Intrastromal femtosecond laser presbyopia correction: 1-year results of a multicenter study. J Refract Surg. 2012;28(3):182-8.

21. Krueger RR, Uy H, McDonald J, Edwards K. Ultrashort-pulse lasers treating the crystalline lens: will they cause vision-threatening cataract? (An American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2012;110:130-65.